home / stock / nvro / nvro quote
Last: | $9.30 |
---|---|
Change Percent: | -4.52% |
Open: | $9.78 |
Close: | $9.74 |
High: | $9.8 |
Low: | $9.3 |
Volume: | 60,057 |
Last Trade Date Time: | 07/29/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$9.3 | $9.78 | $9.74 | $9.8 | $9.3 | 60,057 | 07-29-2024 |
$9.74 | $10.14 | $9.74 | $10.14 | $9.62 | 445,625 | 07-26-2024 |
$9.88 | $9.71 | $9.88 | $10.29 | $9.71 | 433,566 | 07-25-2024 |
$9.74 | $9.75 | $9.74 | $9.97 | $9.7 | 301,082 | 07-24-2024 |
$9.83 | $9.39 | $9.83 | $9.92 | $9.31 | 460,165 | 07-23-2024 |
$9.5 | $9.14 | $9.5 | $9.575 | $8.86 | 365,501 | 07-22-2024 |
$9.1 | $9.47 | $9.1 | $9.575 | $9.05 | 455,509 | 07-19-2024 |
$9.47 | $9.99 | $9.47 | $10.28 | $9.39 | 324,375 | 07-18-2024 |
$10.09 | $9.91 | $10.09 | $10.37 | $9.77 | 464,192 | 07-17-2024 |
$10.1 | $9.64 | $10.1 | $10.21 | $9.64 | 465,277 | 07-16-2024 |
$9.54 | $9.18 | $9.54 | $9.6 | $9.075 | 528,965 | 07-15-2024 |
$9.17 | $9 | $9.17 | $9.4 | $8.96 | 589,895 | 07-12-2024 |
$8.81 | $8.24 | $8.81 | $9.27 | $8.24 | 727,788 | 07-11-2024 |
$8.01 | $7.65 | $8.01 | $8.2591 | $7.51 | 758,956 | 07-10-2024 |
$7.61 | $8.21 | $7.61 | $8.2378 | $7.46 | 954,374 | 07-09-2024 |
$8.37 | $8.62 | $8.37 | $8.82 | $8.36 | 339,964 | 07-08-2024 |
$8.61 | $8.37 | $8.61 | $8.65 | $8.2551 | 223,047 | 07-05-2024 |
$8.38 | $8.35 | $8.38 | $8.43 | $8.22 | 166,365 | 07-04-2024 |
$8.38 | $8.35 | $8.38 | $8.43 | $8.22 | 166,365 | 07-03-2024 |
$8.35 | $8.67 | $8.35 | $8.67 | $8.22 | 326,426 | 07-02-2024 |
News, Short Squeeze, Breakout and More Instantly...
Nevro to Report Second-Quarter 2024 Financial Results and Host Earnings Conference Call on August 6, 2024 PR Newswire REDWOOD CITY, Calif. , July 9, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company delivering comprehensive, life-chan...
Nevro to Present at Truist Securities MedTech Conference PR Newswire REDWOOD CITY, Calif. , June 11 , 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chr...
Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08 PR Newswire REDWOOD CITY, Calif. , May 24, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the trea...